Medical Laboratories

The MCTS will determine the efficacy of multiple therapies to treat patients with major bleeding. Use of the MCTS will support physicians’ decisions when selecting treatment individualized for each patient. While initially intended for use during cardiac surgery, future intended uses are planned to include major bleeding during other types of surgery. Information provided by the MCTS will be especially useful in hospitals that do not perform coagulation factor levels on a STAT basis.